- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Non-radiographic axial spondyloarthritis (nr-AxSpA)
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 910KB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 503KB)
Ixekizumab – July 2023
Ixekizumab: Injection 80 mg in 1 mL single dose pre-filled pen, Taltz® - July 2023
Last updated
10 November 2023